VaxCelerate II: Rapid development of a self-assembling vaccine for Lassa fever-Reference-Cited by-同舟云学术

VaxCelerate II: Rapid development of a self-assembling vaccine for Lassa fever

Published:2014-10-03 Issue:10 Volume:10 Page:3022-3038
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Leblanc Pierre¹,Moise Leonard²,Luza Cybelle¹,Chantaralawan Kanawat¹,Lezeau Lynchy¹,Yuan Jianping¹,Field Mary¹,Richer Daniel¹,Boyle Christine²,Martin William D²,Fishman Jordan B³,Berg Eric A³,Baker David⁴,Zeigler Brandon⁵,Mais Dale E⁵,Taylor William⁶,Coleman Russell⁶,Warren H Shaw⁷,Gelfand Jeffrey A¹,De Groot Anne S²,Brauns Timothy¹,Poznansky Mark C¹

Affiliation:

1. Vaccine and Immunotherapy Center; Massachusetts General Hospital; Charlestown, MA USA

2. EpiVax, Inc.; Providence, RI USA

3. 21st Century Biochemicals; Marlboro, MA USA

4. University of Washington; Department of Biochemistry and Howard Hughes Medical Institute; Seattle, Washington USA

5. MPI Research; Kalamazoo, MI USA

6. Pfenex Inc.; San Diego, CA USA

7. Pediatric Infectious Diseases; Massachusetts General Hospital; Boston, MA USA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy